CIK 0001714899
- Large accelerated filer
Denali Therapeutics Inc.
Sign in to watch- Ticker
- DNLI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 463872213
- Phone
- +1 650-866-8547
- Business address
- 161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $363,678
- in 3 filings, $327K under 10b5-1 plans
Net −$363,678. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-12 | Watts Ryan J. President and CEO | Gift | −32,220 | 2,120,384 | ||
| 2026-01-06 | Watts Ryan J. President and CEO | Sale | −35,198 | $16.50 | $581K | 296,833 |
| 2026-01-03 | Watts Ryan J. President and CEO | Grant or award | +78,960 | 332,031 | ||
| 2026-01-03 | Watts Ryan J. President and CEO | Grant or award · Stock Option (right to buy) | +236,880 | 236,880 | ||
| 2025-09-03 | Watts Ryan J. President and CEO | Gift | −50,000 | 2,152,604 | ||
| 2025-07-09 | Watts Ryan J. President and CEO | Option exercise 10b5-1 | +455,282 | $0.68 | $310K | 708,353 |
| 2025-07-09 | Watts Ryan J. President and CEO | Option exercise 10b5-1 | +40,000 | $5.28 | $211K | 748,353 |
| 2025-07-09 | Watts Ryan J. President and CEO | Sale 10b5-1 | −495,282 | $15.00 | $7.4M | 253,071 |
| 2025-07-09 | Watts Ryan J. President and CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −455,282 | 622,809 | ||
| 2025-07-09 | Watts Ryan J. President and CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −40,000 | 20,369 | ||
| 2025-01-07 | Watts Ryan J. President and CEO | Sale | −7,650 | $20.81 | $159K | 253,071 |
| 2025-01-06 | Watts Ryan J. President and CEO | Sale | −29,266 | $20.22 | $592K | 260,721 |
| 2025-01-03 | Watts Ryan J. President and CEO | Grant or award | +54,180 | 289,987 | ||
| 2025-01-03 | Watts Ryan J. President and CEO | Grant or award · Stock Option (right to buy) | +162,540 | 162,540 | ||
| 2024-10-18 | Watts Ryan J. President and CEO | Option exercise 10b5-1 | +40,000 | $0.68 | $27K | 275,807 |
| 2024-10-18 | Watts Ryan J. President and CEO | Sale 10b5-1 | −40,000 | $27.69 | $1.1M | 235,807 |
| 2024-10-18 | Watts Ryan J. President and CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −40,000 | 1,078,091 | ||
| 2024-08-20 | Watts Ryan J. President and CEO | Sale | −2,260 | $23.79 | $54K | 235,807 |
| 2024-03-29 | Watts Ryan J. President and CEO | Gift | −40,000 | 2,202,604 | ||
| 2024-02-13 | Watts Ryan J. President and CEO | Sale | −9,589 | $17.29 | $166K | 238,067 |
Page 1 of 10 · 181 trades